200 Participants Needed

Support-t Online Training for Type 1 Diabetes Transition Care

(Support-t Trial)

Recruiting at 3 trial locations
AB
AR
Overseen ByAmelie Roy-Fleming, MSc
Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: Anne-Sophie Brazeau
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It seems focused on online training and support, so it's likely you can continue your usual diabetes care.

What data supports the effectiveness of the treatment Support-t Online Training for Type 1 Diabetes Transition Care?

The research on a similar eHealth tool for self-management in type 1 diabetes showed that it was well accepted by users and had a positive impact on learning self-management skills, which could help prevent complications related to diabetes.12345

How is the Support-t Online Training treatment for Type 1 Diabetes unique?

Support-t Online Training is unique because it focuses on helping young adults transition from pediatric to adult diabetes care, aiming to improve clinic attendance, diabetes control, and reduce hospital admissions. Unlike traditional treatments that focus solely on medical management, this program provides structured support during a critical life stage, addressing both medical and psychosocial needs.678910

What is the purpose of this trial?

The investigators will conduct a randomized controlled trial (RCT) to examine how an online training and peer support platform could help the preparation to transition to adult care. Among 14-16 year old youth with Type 1 Diabetes (T1D), the investigators aim to assess the effect of an online training and peer support platform (Support-t) integrated in usual care, compared with usual care on Hemoglobin A1c (HbA1c), adverse outcomes and psychosocial measures during the preparation for transition to adult care. The investigators will conduct a multi-site, parallel group, blinded (outcome assessors, data analysts), superiority RCT of adolescents with T1D (14-16 years of age) followed at one of 4 university teaching hospital-based pediatric diabetes clinics in the province of Quebec.

Research Team

AB

Anne-Sophie Brazeau, PhD

Principal Investigator

School of Human Nutrition - McGill University

Eligibility Criteria

This trial is for 14-16 year olds with Type 1 Diabetes who are patients at one of four specific pediatric diabetes clinics in Quebec. They must have internet access, an active email, and speak English or French. It's not specified who can't join.

Inclusion Criteria

I am a teenager diagnosed with Type 1 Diabetes.
Having access to internet
I am between 14 and 16 years old.
See 2 more

Exclusion Criteria

Severe neurocognitive disabilities
I have a condition like hemolytic anemia that affects my red blood cell lifespan.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants receive access to the Support-t online training and peer support platform in addition to usual diabetes care

18 months
Regular visits as per usual diabetes care

Follow-up

Participants are monitored for changes in HbA1c and other secondary outcomes

18 months
Assessments at baseline, 6, 12, and 18 months

Post-study Access

Control group participants have the option to use the Support-t platform after the 18-month study

Treatment Details

Interventions

  • Support-t
Trial Overview The study tests 'Support-t', an online training and peer support platform designed to help youths with Type 1 Diabetes as they prepare to move from child to adult care services. The effect on blood sugar control, health outcomes, and mental well-being will be compared with usual care.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Support-t plus usual diabetes careExperimental Treatment1 Intervention
Access to the Support-t online training and peer support platform in addition to usual diabetes care for 18 months. Support-t contains 3 components: 1) Educational material, 2) News blog and 3) Patients' discussion forum. Health care providers from the pediatric diabetes clinics will receive Support-t training and will be encouraged to recommend the Support-t platform during routine care with their patients from the active arm.
Group II: Usual diabetes care onlyActive Control1 Intervention
Usual diabetes care for 18 months, which consists of visits with their health care provider and ad-hoc diabetes education with nurses and dietitians. Health care providers from the pediatric diabetes clinics will be instructed not to discuss or refer to the Support-t platform with patients from the control arm. Control arm participants will have the option to use the Support-t platform after the 18-month study.

Support-t is already approved in Canada for the following indications:

🇨🇦
Approved in Canada as Support-t for:
  • Type 1 Diabetes Transition Support

Find a Clinic Near You

Who Is Running the Clinical Trial?

Anne-Sophie Brazeau

Lead Sponsor

Trials
1
Recruited
200+

McGill University

Lead Sponsor

Trials
421
Recruited
1,017,000+

CHU de Quebec-Universite Laval

Collaborator

Trials
177
Recruited
110,000+

McGill University Health Centre/Research Institute of the McGill University Health Centre

Collaborator

Trials
476
Recruited
170,000+

Centre de recherche du Centre hospitalier universitaire de Sherbrooke

Collaborator

Trials
64
Recruited
33,600+

CSSS de Gatineau

Collaborator

Trials
2
Recruited
250+

Findings from Research

A pilot study involving 35 participants with type 1 diabetes demonstrated that a user-centered eHealth tool for functional insulin therapy (FIT) was well accepted and positively impacted learning outcomes.
The study found strong correlations between users' success in learning tasks and their perceived utility, educational adequacy, and ease of use of the tool, suggesting it effectively supports self-management skills in diabetes.
User-centered approach in the development of an eHealth tool for self-management skills in functional insulin therapy to prevent complications of diabetes.Fezzi, C., Refahi, H., Albuisson, E., et al.[2022]
A study involving 35 patients with type 1 diabetes showed that insulin pump user retraining significantly improved their knowledge and application skills related to insulin management, leading to better glycemic control as indicated by a reduction in HbA1c levels.
Despite the improvements in knowledge and metabolic parameters, the retraining did not result in significant changes in quality of life or treatment satisfaction, suggesting that while retraining is beneficial for managing diabetes, it may not address all aspects of patient experience.
The Effect of Retraining on Treatment Success, Quality of Life, and Metabolic Parameters in Patients with Type 1 Diabetes Using an Insulin Pump.Ozgen Saydam, B., Yilmazmis, F., Aydin, N., et al.[2022]
Patients with type 1 diabetes who attended structured education programs reported varying preferences for social support, which influenced their self-management practices and ability to sustain new skills over time.
The study found that patients often sought more social support after learning self-management skills, but the effectiveness of this support could be hindered by outdated knowledge from family members, highlighting the need for better education for patients' social networks.
Type 1 diabetes patients' experiences of, and need for, social support after attending a structured education programme: a qualitative longitudinal investigation.Rankin, D., Barnard, K., Elliott, J., et al.[2022]

References

User-centered approach in the development of an eHealth tool for self-management skills in functional insulin therapy to prevent complications of diabetes. [2022]
The Effect of Retraining on Treatment Success, Quality of Life, and Metabolic Parameters in Patients with Type 1 Diabetes Using an Insulin Pump. [2022]
Type 1 diabetes patients' experiences of, and need for, social support after attending a structured education programme: a qualitative longitudinal investigation. [2022]
Patient and Healthcare Professionals Perspectives on the Delivery of Exercise Education for Patients With Type 1 Diabetes. [2021]
Design, construction, and implementation of an online platform for patients with type 1 diabetes: EncoDiab. [2020]
A transition care programme which improves diabetes control and reduces hospital admission rates in young adults with Type 1 diabetes aged 15-25 years. [2022]
Closing the Gap: Results of the Multicenter Canadian Randomized Controlled Trial of Structured Transition in Young Adults With Type 1 Diabetes. [2022]
Development and design of the first structured clinic-based program in lower resource settings to transition emerging adults with type 1 diabetes from pediatric to adult care. [2023]
Adult care providers' perspectives on the transition to adult care for emerging adults with Type 1 diabetes: a cross-sectional survey. [2019]
[Building bridges during transition of patients with type 1 diabetes. Adult medical and pediatric point of views]. [2021]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security